GE Healthcare has received FDA approval for the End-tidal Control program for general anesthesia on the Aisys CS2Anesthesia Delivery System. The company is the only manufacturer to receive approval for the program to automate the administration of anesthesia during surgery in the United States. Using the system will reduce surgical costs by 27%. The company will begin selling Aisys CS2 with Et Control in the U.S. in the coming months.